Your browser doesn't support javascript.
[French clinical practice guidelines developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic disease]. / Indications de vitrification ovocytaire dans les pathologies gynécologiques bénignes : conseils de bonne pratique du CNGOF après étude de consensus par méthode Delphi.
Courbiere, B; Le Roux, E; Mathieu d'Argent, E; Torre, A; Patrat, C; Poncelet, C; Montagut, J; Gremeau, A-S; Creux, H; Peigne, M; Chanavaz-Lacheray, I; Dirian, L; Fritel, X; Pouly, J-L; Fauconnier, A.
  • Courbiere B; Department of gynecology-obstetric and reproductive medicine, hôpital La Conception, AP-HM, Marseille, France; Aix-Marseille université IMBE, CNRS, IRD, Avignon université, Marseille, France. Electronic address: Blandine.courbiere@univ-amu.fr.
  • Le Roux E; Inserm, CIC 1426, unité d'épidémiologie clinique, hôpital universitaire Robert-Debré, AP-HP Nord-université de Paris, Paris, France; Inserm, ECEVE UMR 1123, université de Paris, Paris, France.
  • Mathieu d'Argent E; Department of gynecology-obstetric and reproductive medicine, GRC6-UPMC, centre expert en endométriose (C3E), université Pierre-et-Marie-Curie Paris 6, hôpital Tenon, CHU de Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France.
  • Torre A; Department of gynecology-obstetric and reproductive medicine, CHU Rouen, 37, boulevard Gambetta, 76000 Rouen, France.
  • Patrat C; Inserm U1016, service de biologie de la reproduction - CECOS, AP-HP centre - université de Paris, site Cochin, 24, rue du Faubourg-Saint-Jacques, 75014 Paris, France.
  • Poncelet C; Department of gynecology - obstetrics/UFR SMBH Leonard de Vinci, centre hospitalier de René Dubos/université Sorbonne Paris Nord - université Paris 13, Cergy-Pontoise, France.
  • Montagut J; Institut francophone de recherche et d'études appliquées à la reproduction, Ifreares Toulouse, Toulouse, France.
  • Gremeau AS; Department of gynecologic surgery and IVF, university hospital Clermont-Ferrand, Clermont-Ferrand, France.
  • Creux H; Department of gynecology-obstetric and reproductive medicine, clinique Saint-Roch, Montpellier, France.
  • Peigne M; Department of reproductive medicine and fertility preservation, hôpital Jean-Verdier, université Sorbonne Paris Nord-Paris 13, AP-HP, Bondy, France.
  • Chanavaz-Lacheray I; Clinique Tivoli Ducos, centre d'endométriose, Bordeaux, France.
  • Dirian L; EndoFrance, Association française de lutte contre l'endométriose, Paris, France.
  • Fritel X; Inserm CIC-P 1402, department of gynecology-obstetric and reproductive medicine, CHU Poitiers, Poitiers, France.
  • Pouly JL; Department of gynecology-obstetric, centre hospitalier Moulins Yzeure, Moulins, France.
  • Fauconnier A; Department of gynecology and obstetrics/research unit 7285 risk and safety in clinical medicine for women and perinatal health, CHI Poissy-Saint-Germain-en Laye/Paris-Saclay university, Poissy, France.
Gynecol Obstet Fertil Senol ; 50(3): 211-219, 2022 03.
Article in French | MEDLINE | ID: covidwho-1641270
ABSTRACT

OBJECTIVES:

To provide clinical practice guidelines about fertility preservation (FP) for women with benign gynecologic disease (BGD) developed by a modified Delphi consensus process for oocyte vitrification in women with benign gynecologic disease.

METHODS:

A steering committee composed of 14 healthcare professionals and a patient representative with lived experience of endometriosis identified 42 potential practices related to FP for BGD. Then 114 key stakeholders including various healthcare professionals (n=108) and patient representatives (n=6) were asked to participate in a modified Delphi process via two online survey rounds from February to September 2020 and a final meeting. Due to the COVID-19 pandemic, this final meeting to reach consensus was held as a videoconference in November 2020.

RESULTS:

Survey response of stakeholders was 75 % (86/114) for round 1 and 87 % (75/86) for round 2. Consensus was reached for the recommendations for 28 items, that have been distributed into five general categories (i) Information to provide to women of reproductive age with a BGD, (ii) Technical aspects of FP for BGD, (iii) Indications for FP in endometriosis, (iv) Indications for FP for non-endometriosis BGD, (v) Indications for FP after a fortuitous diagnosis of an idiopathic diminished ovarian reserve.

CONCLUSION:

These guidelines provide some practice advice to help health professionals better inform women about the possibilities of cryopreserving their oocytes prior to the management of a BGD that may affect their ovarian reserve and fertility. STUDY FUNDING/COMPETING INTEREST(S) The CNGOF (Collège National des Gynécologues Obstétriciens Français) funded the implementation of the Delphi process.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Endometriosis / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans Language: French Journal: Gynecol Obstet Fertil Senol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Endometriosis / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Female / Humans Language: French Journal: Gynecol Obstet Fertil Senol Year: 2022 Document Type: Article